Two Sigma Investments, LP Molecular Templates, Inc. Transaction History

Two Sigma Investments, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.33 - $12.0 $19,161 - $696,768	-58,064 Reduced 26.48%	161,231 $53,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $11.25 $30,578 - $505,901	-44,969 Reduced 17.02%	219,295 $164,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $3.43 $73,655 - $311,900	90,933 Added 52.46%	264,264 $241,000
Q1 2022 May 16, 2022	SELL	$2.27 - $4.13 $291,068 - $529,565	-128,224 Reduced 42.52%	173,331 $598,000
Q4 2021 Feb 14, 2022	SELL	$3.37 - $6.87 $24,968 - $50,899	-7,409 Reduced 2.4%	301,555 $1.18 Million
Q3 2021 Nov 15, 2021	BUY	$5.78 - $7.86 $1.14 Million - $1.55 Million	196,766 Added 175.37%	308,964 $2.07 Million
Q2 2021 Aug 16, 2021	BUY	$7.82 - $12.44 $424,469 - $675,243	54,280 Added 93.72%	112,198 $877,000
Q1 2021 May 17, 2021	SELL	$9.33 - $14.05 $1.41 Million - $2.12 Million	-151,008 Reduced 72.28%	57,918 $731,000
Q4 2020 Feb 16, 2021	BUY	$8.48 - $12.23 $910,811 - $1.31 Million	107,407 Added 105.8%	208,926 $1.96 Million
Q3 2020 Nov 16, 2020	SELL	$9.99 - $14.41 $203,975 - $294,223	-20,418 Reduced 16.74%	101,519 $1.11 Million
Q2 2020 Aug 14, 2020	BUY	$12.28 - $17.63 $1.16 Million - $1.67 Million	94,723 Added 348.07%	121,937 $1.68 Million
Q1 2020 May 15, 2020	SELL	$11.31 - $18.26 $436,611 - $704,909	-38,604 Reduced 58.65%	27,214 $362,000
Q4 2019 Feb 14, 2020	BUY	$6.44 - $14.21 $423,867 - $935,273	65,818 New	65,818 $920,000
Q1 2018 May 15, 2018	SELL	$8.0 - $12.96 $104,888 - $169,918	-13,111 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$7.04 - $11.31 $92,301 - $148,285	13,111	13,111 $131,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.